Deep Tech Startups

Hot Lime Labs develops patented limestone-based CO2 capture technology that captures and releases CO2 and heat on demand for the decarbonization of hard-to-abate industries such as horticulture, hydrogen production, and gas cleaning. Its first application, providing heat and CO2 for commercial greenhouses, has been demonstrated and is being commercialized through Aplenty.

2 investors

Hushmesh operates the Mesh, a cryptographic infrastructure that gives every person, agent, and data object a globally verified identity, keychain, and encrypted space to assure data provenance, integrity, and privacy. It targets organizations deploying autonomous agents that need to coordinate and transact with verifiable, agent-centric cryptographic security.

2 investors

Hychor develops HySET, an electrochemical technology that produces green hydrogen from seawater and renewable electricity, reducing reliance on freshwater and grid connection. Spun out of the University of Aberdeen, the company works on system design, materials testing, and scale-up ahead of planned industry projects.

2 investors

HyperSciences develops a hypersonic accelerator engine aimed at mining and tunneling applications. The company applies high-speed projectile technology to excavation and boring in these industries.

2 investors

Hypetex Coloured Advanced Materials (CAM) develops sustainable colouring technology for advanced engineered materials such as carbon fibre and flax, offering a portfolio of colour and material combinations along with technical, design and manufacturing support. It also produces FlaxTex, a coated natural fibre for colouring and improving the processing of flax, serving composite manufacturing programmes.

2 investors

iCorNet develops a tailored cardiac remodeling prevention net using 3D cardiac imaging and computer-controlled knitting technology to treat dilated cardiomyopathy. The device is designed for heart failure patients who do not respond adequately to drug therapy and cannot access cardiac transplantation.

2 investors

IDUN Technologies makes the Guardian 4, consumer earbuds with in-ear EEG and 9-axis motion sensors that record brainwave and movement data while playing audio. It provides web and mobile apps, a Python/TS SDK, and a public API with EEG classifiers for developers and researchers building neuro-feedback and wellness applications.

2 investors

IENAI develops end-to-end propulsion and mobility systems for small satellites, providing in-orbit maneuvering products for spacecraft operators. It targets the small satellite segment of the space industry.

2 investors

International Geoscience Services (IGS) Ltd is a consultancy that collects, processes, interprets, and quality-controls geological, geophysical, and geochemical data to support mineral exploration. It works with national governments, ministries of mines, geological surveys, development agencies such as the World Bank, and exploration companies, offering services including remote sensing, 3D geological modelling, QA/QC, field mapping, institutional reform, and capacity building.

2 investors

ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform. The company operates in the drug development and pharmaceutical industry.

2 investors

Imacreate develops, operates, and consults on VR/AR/MR systems, with a focus on "doing" rather than "watching" XR experiences applied to skills training (e.g. welding training with the Kobe Steel group). The company builds XR systems aimed at improving human abilities and delivering results in physical reality, serving industrial and manufacturing clients.

2 investors

Imandra builds CodeLogician, a neurosymbolic AI tool that translates source code into formal mathematical models to prove code properties, find bugs, and generate test cases. It integrates with AI coding assistants and targets software developers and regulated industries such as finance through its Imandra Universe reasoning ecosystem.

2 investors

Imbue builds an open agent ecosystem that lets users understand, modify, and verify AI agents so they operate in the user's interest rather than a platform's. Founded in 2021, the company develops AI systems aimed at keeping humans in control, and offers space to small teams building user-loyal software.

2 investors

Immitra Bio develops an in-vivo stem cell therapy platform designed to treat rare genetic diseases, particularly severe inherited red blood cell disorders, by replacing complex transplants with single off-the-shelf treatments. The company is an ETH Zürich spin-off focused on precision medicine and gene editing approaches for genetic disease intervention.

2 investors

ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

2 investors

Immunito AI is an in-silico antibody discovery company that combines artificial intelligence with an in-house biological lab to speed up and improve the discovery of antibodies. It serves the biotech and biopharmaceutical industry.

2 investors

NapaJen Pharma is a biopharmaceutical research and development company developing nucleic acid (oligonucleotide) drugs using a proprietary cell-specific drug delivery platform that enables delivery to immune cells for precision-targeted immunosuppression and controlled immuno-stimulation. It develops its own drug candidates and partners with other pharmaceutical companies applying its delivery technology.

2 investors

Impossible Objects develops composite-based 3D printing technology. The company operates in the additive manufacturing and hardware sector.

2 investors

In Orbit develops orbital warehousing and advanced transportation systems for cargo management and distribution. The company provides responsive and efficient cargo delivery solutions using space-based infrastructure.

2 investors

Inaedis develops RTAD (Room Temperature Aerosol Dehydration), a cGMP-compatible technology that converts liquid biologic drugs and vaccines into room-temperature-stable powder and suspension formulations, enabling routes such as subcutaneous, inhaled, and intranasal delivery. It serves pharmaceutical, public health, and defense customers seeking cold-chain-free biologics and higher-concentration formulations, based on technology licensed from Princeton University.

2 investors

Inductosense develops the WAND system, which uses ultrasonic sensors to digitize wall thickness monitoring and corrosion inspection of industrial assets. It serves sectors including oil and gas, chemical, mining, renewables, and nuclear, and works with original equipment manufacturers to integrate the technology.

2 investors

Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.

2 investors

Infinite Cooling develops patented technology to capture airborne water droplets and improve the efficiency of evaporative cooling systems such as cooling towers, aiming to reduce water use and energy consumption for industrial customers like power plants. Spun out of an MIT lab in 2019, the company builds and tests its products at its manufacturing facility in Massachusetts.

2 investors

Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins. The technology, developed at Johns Hopkins University's Laboratory of Precision Immunology, is used for immunology and diagnostics research.

2 investors